Min-Ho Nam, K.M.D., Ph.D.
Affiliations: | 2004-2013 | College of Korean Medicine | Kyung Hee University, Seoul, South Korea |
2013- | Brain Science Institute | Korea Institute of Science and Technology, Daejeon, South Korea |
Area:
Astrocyte, Parkinson's disease, Neuroinflammation, Reactive astrocyte, AcupunctureWebsite:
nam-lab.orgGoogle:
"Min-Ho Nam"Mean distance: 16.77 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentorChangjoon Justin Lee | grad student | 2013-2017 | Korea Institute of Science and Technology |
Children
Sign in to add traineeHyowon Lee | grad student | 2020- | Korea Institute of Science and Technology |
Eun-Bin Hong | grad student | 2022- | Yonsei University |
Hyunjin Kim | grad student | 2022- | Korea Institute of Science and Technology |
Juyeong Cho | research scientist | 2022- | Korea Institute of Science and Technology |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Kim D, Ko HY, Chung JI, et al. (2023) Visualizing Cancer-Originating Acetate Uptake Through MCT1 in Reactive Astrocytes in the Glioblastoma Tumor Microenvironment. Neuro-Oncology |
Nam MH, Ko HY, Kim D, et al. (2023) Visualizing reactive astrocyte-neuron interaction in Alzheimer's disease using 11C-acetate and 18F-FDG. Brain : a Journal of Neurology |
Seo DC, Ju YH, Seo JJ, et al. (2023) DDC-Promoter-Driven Chemogenetic Activation of SNpc Dopaminergic Neurons Alleviates Parkinsonian Motor Symptoms. International Journal of Molecular Sciences. 24 |
Kim D, Chun JH, Yi JH, et al. (2022) 11C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification. Clinical Nuclear Medicine |
Nam MH, Sa M, Ju YH, et al. (2022) Revisiting the Role of Astrocytic MAOB in Parkinson's Disease. International Journal of Molecular Sciences. 23 |
Kim H, Nam MH, Jeong S, et al. (2022) Visualization of differential GPCR crosstalk in DRD1-DRD2 heterodimer upon different dopamine levels. Progress in Neurobiology. 102266 |
Yoon HH, Ye S, Lim S, et al. (2022) CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease . The Crispr Journal. 5: 95-108 |
Nam MH, Park JH, Song HJ, et al. (2021) KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics |
Cho HU, Kim S, Sim J, et al. (2021) Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis. Experimental & Molecular Medicine |
An H, Koh W, Kang S, et al. (2021) Differential Proximity of Perisynaptic Astrocytic Best1 at the Excitatory and Inhibitory Tripartite Synapses in APP/PS1 and MAOB-KO Mice Revealed by Lattice Structured Illumination Microscopy. Experimental Neurobiology |